Revolutionary Cannabis Spray. The New Diabetes Breakthrough?
In a landmark study titled “A Phase I Randomized, Double-Blind, Placebo-Controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol-Delta 9-Tetrahydrocannabinol 10:1 Regimen in Diabetes Type 2 Patients,” a team of researchers led by Shima Afshar delved into the potential of cannabis in treating Type 2 Diabetes. This study is pivotal in understanding … Read more